Detalles de la búsqueda
1.
γ134.5-deleted HSV-1-expressing human cytomegalovirus IRS1 gene kills human glioblastoma cells as efficiently as wild-type HSV-1 in normoxia or hypoxia.
Gene Ther
; 22(4): 348-55, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25427614
2.
Assessment of oncolytic HSV efficacy following increased entry-receptor expression in malignant peripheral nerve sheath tumor cell lines.
Gene Ther
; 21(11): 984-90, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25119379
3.
γ134.5-deleted HSV-1-expressing human cytomegalovirus IRS1 gene kills human glioblastoma cells as efficiently as wild-type HSV-1 in normoxia or hypoxia.
Gene Ther
; 22(4): 356, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25832732
4.
Enhanced antiglioma activity of chimeric HCMV/HSV-1 oncolytic viruses.
Gene Ther
; 14(13): 1045-54, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17429445
5.
New therapeutic approaches to the alphaherpesvirus infections.
J Antimicrob Chemother
; 39(2): 119-28, 1997 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-9069530
6.
The herpes simplex virus US11 protein effectively compensates for the gamma1(34.5) gene if present before activation of protein kinase R by precluding its phosphorylation and that of the alpha subunit of eukaryotic translation initiation factor 2.
J Virol
; 72(11): 8620-6, 1998 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-9765401
7.
The second-site mutation in the herpes simplex virus recombinants lacking the gamma134.5 genes precludes shutoff of protein synthesis by blocking the phosphorylation of eIF-2alpha.
J Virol
; 72(9): 7005-11, 1998 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-9696792
Resultados
1 -
7
de 7
1
Próxima >
>>